Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study reveals the hidden toll of nearsightedness on daily life

NCT ID NCT06912802

Knowledge-focused Sponsor: Santen SAS Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how nearsightedness (myopia) affects the quality of life of children and adults. Researchers surveyed parents of nearsighted children and adults with long-term complications from myopia. The goal was to understand the real-world impact of the condition, not to test any treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

344 people

The number who actually took part.

Started

Jul 2025

Finished

Apr 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Children or adolescents aged 5 years or older suffering from myopia (low, moderate, or high myopia) and adults suffering from myopia and its complications such as: cataract, macular degeneration, open-angle glaucoma, retinal detachment, and legal blindness/severe visual impairment.

Ages

5 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Parents (or other proxy) of children or adolescents aged 5 years or older suffering from myopia (low, moderate, or high myopia) defined by their spherical equivalent (SER): Low myopia is from -0.5 D (inclusive) to -3.0 D (inclusive), Moderate myopia is from -3.0 D to -6.0 D (inclusive) and High myopia is \<-6.0 D. * Adults suffering from myopia and its complications such as: cataract, macular degeneration, open-angle glaucoma, retinal detachment, and legal blindness/severe visual impairment. * Patients where myopia is a known or likely contributing factor to the complication. Exclusion Criteria: * Parents (or other proxy) of children aged 4 years and below. * Patients where the complication is likely unrelated to myopia (e.g., cataract caused by diabetes) will be excluded

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Myopia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

myopia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Myopia

Contacts and locations

Locations

  • Copenhagen University Hospital

    Copenhagen, Denmark

  • Estudio Oftalmologico

    Madrid, Spain

  • Klinik für Augenheilkunde (Universitätsklinikum Freiburg)

    Freiburg im Breisgau, Germany

  • Meyer Children's Hospital IRCCS

    Florence, Italy

  • Moorfields Eye Hospital NHS Foundation Trust

    London, United Kingdom

  • Policlinico Universitario Agostino Gemelli IRCCS

    Rome, Italy

  • St. Erik Eye Hospital

    Solna, Sweden

  • The San Carlos Clinic Hospital (Hospital Clinico San Carlos-HCSC)

    Madrid, Spain

  • University Hospital Necker Enfants Malades

    Paris, France

  • Universitäts-Augenklinik Mainz

    Mainz, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.